The global EPA and DHA market is experiencing significant growth due to increasing consumer awareness of preventive healthcare, rising demand for omega-3 supplements, expanding applications in functional foods and pharmaceuticals, and growing prevalence of cardiovascular and lifestyle-related diseases. The global EPA and DHA market size was valued at USD 1.99 billion in 2025 and is projected to grow from USD 2.13 billion in 2026 to USD 3.73 billion by 2034, registering a CAGR of 7.24% during the forecast period (2026–2034).

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) are long-chain omega-3 fatty acids primarily derived from fish oil, krill oil, algal oil, and other marine sources. They play a vital role in supporting cardiovascular health, brain development, eye health, immune function, and overall well-being. Increasing consumer preference for nutritional supplements and fortified foods continues to drive market expansion.

Market Drivers

Rising Consumer Awareness of Omega-3 Health Benefits

Growing awareness regarding the role of EPA and DHA in maintaining heart health, cognitive function, and overall wellness is driving global demand for omega-3 products.

Increasing Demand for Dietary Supplements

Consumers are increasingly incorporating EPA and DHA supplements into their daily nutrition routines as part of preventive healthcare and healthy aging strategies.

Expanding Functional Food and Beverage Industry

Food manufacturers are increasingly fortifying dairy products, beverages, infant formula, and nutritional products with omega-3 ingredients to enhance their nutritional value.

Growing Aging Population

The expanding elderly population is increasing demand for nutritional products that support cardiovascular health, joint function, and cognitive performance.

Rising Demand for Infant Nutrition Products

DHA is widely used in infant formula and prenatal nutrition products due to its critical role in brain and eye development during early life stages.

For Detailed Insights, Visit:

https://straitsresearch.com/report/epa-and-dha-market

Market Challenges

Fluctuating Raw Material Supply

The availability of fish oil and other marine resources is influenced by seasonal fishing patterns, environmental regulations, and sustainability concerns.

High Production Costs

Purification, concentration, and extraction of high-quality EPA and DHA require advanced processing technologies, increasing manufacturing costs.

Sustainability Concerns

Growing concerns regarding marine resource depletion are encouraging manufacturers to invest in sustainable sourcing and alternative omega-3 production methods.

Regulatory Compliance

Manufacturers must comply with stringent food safety, pharmaceutical, labeling, and nutritional regulations across different global markets.

Market Segmentation

The EPA and DHA market is segmented based on source, application, end user, and region.

By Source

The market is categorized into:

• Fish Oil

• Algal Oil

• Krill Oil

• Others

Fish oil accounts for the largest market share due to its high EPA and DHA content, established supply chain, and widespread use in dietary supplements and pharmaceuticals.

By Application

The market includes:

• Dietary Supplements

• Functional Foods and Beverages

• Infant Formula

• Pharmaceuticals

• Animal Nutrition

• Others

Dietary supplements dominate the market owing to increasing consumer demand for preventive healthcare products and nutritional wellness solutions.

By End User

The market is segmented into:

• Pharmaceutical Companies

• Nutraceutical Manufacturers

• Food and Beverage Manufacturers

• Animal Feed Manufacturers

• Consumers

Nutraceutical manufacturers represent the largest end-user segment due to increasing production of omega-3 capsules, soft gels, gummies, and functional nutrition products.

By Region

The market is analyzed across:

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

Regional Insights

North America

North America dominates the EPA and DHA market due to strong consumer awareness of omega-3 health benefits, high dietary supplement consumption, advanced nutraceutical industries, and increasing healthcare spending.

Europe

Europe holds a significant market share supported by growing demand for functional foods, increasing aging populations, expanding pharmaceutical applications, and strong regulatory standards for nutritional products.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth due to rising disposable incomes, increasing health consciousness, expanding infant nutrition markets, growing nutraceutical industries, and rising demand for functional foods across China, India, Japan, South Korea, and Southeast Asia.

Latin America

Latin America is experiencing steady market growth driven by increasing adoption of dietary supplements, improving healthcare awareness, and expanding retail availability of omega-3 products.

Middle East & Africa

The region is witnessing gradual growth owing to increasing healthcare investments, rising consumer awareness of preventive nutrition, and expanding demand for functional food products.

Technology Trends and Market Opportunities

The EPA and DHA market is evolving through innovations in algae-based omega-3 production, high-purity concentration technologies, microencapsulation, sustainable marine sourcing, plant-based formulations, and advanced purification processes. Manufacturers are increasingly investing in vegan DHA production, environmentally sustainable extraction technologies, and enhanced bioavailability formulations to meet changing consumer preferences.

Growing investments in personalized nutrition, healthy aging products, sports nutrition, infant nutrition, clinical nutrition, functional beverages, and sustainable omega-3 production are creating significant opportunities for market participants. Furthermore, increasing demand for plant-based EPA and DHA ingredients and clean-label nutritional products is expected to support long-term market growth.

Key Players Analysis

The EPA and DHA market is highly competitive, with leading manufacturers focusing on sustainable sourcing, product innovation, advanced purification technologies, and strategic partnerships.

Major companies operating in the market include:

• DSM-Firmenich

• BASF SE

• KD Pharma Group

• Pelagia AS

• GC Rieber VivoMega AS

• Croda International Plc

• Corbion N.V.

• Epax Norway AS

• Polaris Nutritional Lipids

• Aker BioMarine ASA

These companies continue to invest in algae-based omega-3 production, sustainable marine sourcing, pharmaceutical-grade omega-3 ingredients, and global product expansion to strengthen their positions in the global EPA and DHA market.

Related Report

Omega-3 Market

https://straitsresearch.com/report/omega-3-market

About Us

Straits Research is a leading market research and intelligence organization specializing in analytics, advisory services, and comprehensive market research reports across multiple industries.

Contact Us

Email: sales@straitsresearch.com

U.S. Tel: +1 646 905 0080

U.K. Tel: +44 203 695 0070